BOLT vs ACON
Comparison between Bolt Biotherapeutics Inc (BOLT, Company) and Aclarion Inc (ACON, Company).
Both BOLT and ACON are from the Healthcare sector.
BOLT vs ACON - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
BOLT
$7.67M
ACON
$7.63M
Max Drawdown
Winner
BOLT
99.51%
ACON
100.00%
Sharpe Ratio
Winner
BOLT
-0.18
ACON
-0.49
5Y Beta
BOLT
0.92
Winner
ACON
0.00
Industry
BOLT
Biotechnology
ACON
Health Information Services
P/E Ratio
BOLT
-0.26
Winner
ACON
-0.34
5Y EPS CAGR
BOLT
-16.86%
ACON
N/A
Debt to Equity
BOLT
0.00%
ACON
0.00%
Free Cash Flow Yield
BOLT
N/A
ACON
-95.92%
BOLT vs ACON - Historical Returns
Returns include dividend reinvestment.
1M
BOLT
-8.49%
Winner
ACON
-2.50%
3M
BOLT
-13.92%
Winner
ACON
-6.02%
6M
Winner
BOLT
-22.60%
ACON
-50.79%
1Y
Winner
BOLT
-29.51%
ACON
-57.44%
5Y(CAGR)
Winner
BOLT
-58.34%
ACON
-94.08%
Max(CAGR)
Winner
BOLT
-61.23%
ACON
-94.08%
BOLT vs ACON - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | BOLT | ACON |
|---|---|---|
| 2026 | -31.09% | -37.35% |
| 2025 | -52.04% | -99.64% |
| 2024 | -53.87% | -95.66% |
| 2023 | -18.25% | -64.91% |
| 2022 | -73.03% | -78.68% |
| 2021 | -84.76% | N/A |
BOLT vs ACON Drawdown Comparison
The maximum drawdown for BOLT was -99.51%, occurring on Mar 13, 2026. This drawdown has not yet recovered.
The maximum drawdown for ACON was -100.00%, occurring on Feb 5, 2026. This drawdown has not yet recovered.
The current BOLT drawdown is -99.50%. The current ACON drawdown is -100.00%.
| Rank | BOLT | ACON |
|---|---|---|
| #1 | -99.51% Mar 17, 2021 - Mar 13, 2026 | -100.00% Apr 22, 2022 - Feb 5, 2026 |
| #2 | -22.70% Feb 10, 2021 - Mar 9, 2021 | N/A |
| #3 | -0.51% Mar 12, 2021 - Mar 16, 2021 | N/A |
| #4 | -0.20% Mar 9, 2021 - Mar 11, 2021 | N/A |
Correlation
Correlation between BOLT and ACON is 0.81 which considered as a strong positive correlation - the stocks tend to move together.
0.81
-101
Select Stocks to Compare
Popular: BOLT vs SPYACON vs SPY
More Comparisons
Compare with similar stocks